Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jin Medical International (ZJYL) Receivables - Net (2022 - 2025)

Historic Receivables - Net for Jin Medical International (ZJYL) over the last 4 years, with Q3 2025 value amounting to $6.0 million.

  • Jin Medical International's Receivables - Net rose 82.12% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.0 million, marking a year-over-year increase of 82.12%. This contributed to the annual value of $6.0 million for FY2025, which is 82.12% up from last year.
  • According to the latest figures from Q3 2025, Jin Medical International's Receivables - Net is $6.0 million, which was up 82.12% from $4.2 million recorded in Q1 2025.
  • Over the past 5 years, Jin Medical International's Receivables - Net peaked at $6.0 million during Q3 2025, and registered a low of $3.4 million during Q3 2023.
  • Moreover, its 4-year median value for Receivables - Net was $3.9 million (2023), whereas its average is $4.4 million.
  • Per our database at Business Quant, Jin Medical International's Receivables - Net plummeted by 1102.0% in 2023 and then skyrocketed by 7343.89% in 2024.
  • Over the past 4 years, Jin Medical International's Receivables - Net (Quarter) stood at $3.8 million in 2022, then fell by 11.02% to $3.4 million in 2023, then skyrocketed by 73.44% to $5.9 million in 2024, then rose by 0.82% to $6.0 million in 2025.
  • Its Receivables - Net was $6.0 million in Q3 2025, compared to $4.2 million in Q1 2025 and $5.9 million in Q3 2024.